Skip to content

Clinical trials

Phase 3 Venous Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 3 Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20051
20065
20079
200812
20099
201010
20113
20123
20135
20144
20155
20166
20175
20181
20191
20205
20213
20226
20231
20244
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting17
Terminated15
Unknown status7
Not yet recruiting4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer10
Sanofi8
University Hospital, Brest7
McMaster University5
Ottawa Hospital Research Institute5
Regeneron Pharmaceuticals5
Astellas Pharma Inc4
Boehringer Ingelheim4
Daiichi Sankyo Co., Ltd.4
Crux Biomedical3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism118
Venous Thrombosis38
Pulmonary Embolism32
Neoplasms13
Thrombosis12
Thromboembolism11
Hemorrhage9
Postthrombotic Syndrome5
Atrial Fibrillation2
COVID-192

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.